Anupam Rasayan India Limited Fair Value

ANURAS · Chemicals · Current price ₹1,152.4

Full stock page
DocStoX fair value
₹825
medium confidence · 53/100
Current price
₹1,219
Upside to fair value
-32.3%
Estimate range
₹742 – ₹907
Quality score
2.9 / 10
Model it yourself — Margin of Safety Calculator
Opens pre-filled with Anupam Rasayan India Limited's latest numbers.

Is Anupam Rasayan India Limited undervalued?

We estimate the fair value of Anupam Rasayan India Limited at ₹825 per share, against a market price of ₹1,219. That puts the share price about -32.3% above our estimate, at medium confidence. This is our view of what the business is worth, not a target price or a forecast of where the share price will go.

How this fair value is calculated

This estimate comes from 1 method: Fair multiple (P/E) (₹825). Each is weighted by how well its inputs held up for this company. The full working, including the assumptions and what data was missing, is set out below.

The range around this estimate

Our estimate for Anupam Rasayan India Limited spans ₹742 to ₹907. A margin of safety means buying meaningfully below the estimate: the wider the range, the more room the assumptions leave for error.

How we got this fair value

Every number below is part of the same estimate for Anupam Rasayan India Limited. Nothing here is a target price or a forecast of where the share price will go.

Medium confidence53/100

Workable, with real gaps. Weigh it alongside your own view rather than on its own.

Estimate range ₹742 – ₹907

Why this method for this business

Normalized earnings and EV/EBITDA are most relevant for a specialty chemicals company with cyclical characteristics. Relative PE provides a sector benchmark for comparison.

The models behind the number

Each method is weighted by how well its inputs held up for this company.

Fair multiple (P/E)
₹82510% weight
Normalized earnings (mid-cycle EV/EBITDA)(rejected)
₹1,882

implies a 123× P/E (outside 3–80)

EV / EBITDA(not enough data)

required inputs missing

  • Fair multiple (P/E) was not used as it lacks the depth of normalized earnings and EV/EBITDA for a cyclical business

What was missing

  • Lack of forward EBITDA estimates
  • Limited analyst coverage
  • Uncertainty in export demand

What drives it

15 inputs, grouped by how strong each claim is
ReportedRead from filings or market data. Verifiable, not our opinion.
Sector-median P/E
41.7×

peer-median

Peers used
21

peer-median

EPS (TTM)
15.35 ₹/share

computed

Own-history median P/E
71.59×

reconstructed (one feature, dampened — not a cap)

JudgementOur read of the evidence, not a measurement.
Term: quality
-2.5%

quality 50/100 (weak/erratic returns) → discount

Term: growth
+16.9%

durable ~25% CAGR (ROCE 9% < 12% hurdle (growth not value-accretive)) → premium

Term: capital_allocation
-7.6%

capital allocation: falling ROCE / weak cash generation → discount

Term: financial_strength
-0.5%

financial strength: moderate leverage (D/E 0.5) → neutral

Term: history
+21.5%

history: market paid +72% vs sector, dampened ×0.3 (one feature, not the anchor)

Term: sector_rerating
+0.0%

sector re-rating: no sector-norm history → not used

Term: rate_regime
+1.2%

rates: risk-free 6.9% below ~7.1% normal → higher multiple

Term: risk
+0.0%

risk: no analyst-dispersion signal available → neutral (lowers confidence, not PE)

DerivedFalls out of the inputs above: a model output, not an independent input.
Premium vs sector
+28.8%

fundamentals + macro (not capped at own history)

Fair-multiple confidence
80%

data completeness + term agreement

Fair P/E
53.73×

sector median × ∏(1+term) — Dynamic Fair Multiple

Who computed this

A language model (qwen3:8b) selects the valuation method and the judgement inputs for Anupam Rasayan India Limited: which models suit the business, the moat, the growth and margin assumptions. It does not produce the number. The fair value itself is computed in Python by a deterministic engine (version 2026.08.1) from those inputs, so the same inputs always give the same result and every figure above can be traced to a source.

Estimated 14 Sept 2026. Re-run as new financials and news arrive.

How we value stocks

We estimate what a business is worth from its own economics: cash flows, returns on capital, and a multiple justified by its quality, rather than from where the share price has been. A fair value estimate is a view, not a verdict, and it is only as good as the inputs listed above.

Read the full fair-value methodology

More on Anupam Rasayan India Limited

DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.